Randy Hubbell

Randy Hubbell

Amministratore Delegato presso
Carmell Regen Med Corp.
63 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Randy Hubbell currently works at Carmell Regen Med Corp., as President, Chief Executive Officer & Director from 2016 and Neuraptive Therapeutics, Inc., as Director.
Mr. Hubbell also formerly worked at Longevity Health Holdings, Inc., as President, Chief Executive Officer & Director, Vasca, Inc., as Executive Director-Sales & Marketing in 2000, Cordis Cardiology, as Executive Director-Strategic Alliances, International Business Machines Corp., as Principal in 1993, Johnson & Johnson, as Principal, Boston Scientific Corp., as Principal in 1998, Enmedia, Inc., as Principal, Cardiva Medical, Inc., as Chief Commercial Officer, Johnson & Johnson Pharmaceutical Group, as Vice President-Global Strategic Marketing, and Ethicon Biosurgery Ireland, as Vice President-Global Strategic Marketing.
Mr. Hubbell received his Masters Business Admin degree from Loyola University New Orleans and undergraduate degree from Tulane University (Louisiana).

Posizioni attive di Randy Hubbell

SocietàPosizioneInizio
Amministratore Delegato 16/02/2016
Direttore/Membro del Consiglio -

Precedenti posizioni note di Randy Hubbell

SocietàPosizioneFine
LONGEVITY HEALTH HOLDINGS, INC. Amministratore Delegato 31/08/2023
Vendite & Marketing 01/01/2000
BOSTON SCIENTIFIC CORPORATION Corporate Officer/Principal 01/01/1998
IBM Corporate Officer/Principal 01/01/1993
Enmedia, Inc.
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Randy Hubbell

Formazione di Randy Hubbell

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

87

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Technology Services

Health Technology

Health Technology

Health Technology

Enmedia, Inc.

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Johnson & Johnson Pharmaceutical Group

Ethicon Biosurgery Ireland

Commercial Services

Finance

  1. Mercati
  2. Insiders
  3. Randy Hubbell
- 40% : I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA